NASDAQ:TGTX

Tg Therapeutics Stock Predictions

etoro logo Buy TGTX
*Your capital is at risk
$40.11
+3.47 (+9.47%)
At Close: Jun 03, 2026
Currently predicting for Fri, 5 Jun 2026

TGTX Prediction Chart

TGTX Predictions History

Latest community submissions for TGTX.
Predictor Target Session Target Price Result Direction Accuracy Score
May 5, 2025 Bullish $37.68 X 0
Apr 2, 2025 $38.58 +2.21% $39.82 V 96.90% 1
Apr 2, 2025 $38.27 +1.38% $39.82 V 96.11% 1
Mar 26, 2025 $41.98 -1.92% $40.79 V 97.08% 1
Mar 26, 2025 $42.29 -1.20% $40.79 V 96.33% 1
Mar 26, 2025 Bullish $40.79 X 0
Mar 25, 2025 $41.75 -2.01% $42.80 X 97.55% 0
Mar 25, 2025 $42.07 -1.26% $42.80 X 98.30% 0
Mar 25, 2025 Bullish $42.80 X 1
Jan 29, 2025 $32.77 -2.03% $33.37 V 98.20% 1
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for TGTX with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT TG THERAPEUTICS
TG Therapeutics
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hodgkin lymphoma, chronic lymphocytic leukemia (CLL), and relapsing forms of multiple sclerosis; and Umbra...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE